Search Results - "Silk, D B"

Refine Results
  1. 1

    Clinical trial: the effects of a trans‐galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome by SILK, D. B. A., DAVIS, A., VULEVIC, J., TZORTZIS, G., GIBSON, G. R.

    Published in Alimentary pharmacology & therapeutics (01-03-2009)
    “…Summary Background  Gut microflora‐mucosal interactions may be involved in the pathogenesis of irritable bowel syndrome (IBS). Aim  To investigate the efficacy…”
    Get full text
    Journal Article
  2. 2

    Systematic review and meta‐analysis: the clinical and physiological effects of fibre‐containing enteral formulae by ELIA, M., ENGFER, M. B., GREEN, C. J., SILK, D. B. A.

    Published in Alimentary pharmacology & therapeutics (15-01-2008)
    “…Summary Background  Enteral nutrition can be associated with gastrointestinal side effects and fibre supplementation has been proposed as a means to normalize…”
    Get full text
    Journal Article
  3. 3

    The Evolving Role of Post–Ligament of Trietz Nasojejunal Feeding in Enteral Nutrition and the Need for Improved Feeding Tube Design and Placement Methods by Silk, D. B. A.

    “…Nutrition support is an important link in the chain of therapy for intensive care unit patients. The early institution of nutrition support significantly…”
    Get full text
    Journal Article
  4. 4

    Formulation of enteral diets for use in jejunal enteral feeding by Silk, DB. A.

    Published in Proceedings of the Nutrition Society (01-08-2008)
    “…Nasogastric enteral feeding is not tolerated in patients with gastric atony and in many critically-ill patients in whom gastric emptying may be delayed and in…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    Impact of irritable bowel syndrome on personal relationships and working practices by Silk, David B

    “…OBJECTIVE To determine the impact of irritable bowel syndrome on personal relationships and working practices. PATIENTS AND METHODS A 60-item questionnaire…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Chronic idiopathic intestinal pseudo-obstruction: the need for a multidisciplinary approach to management by Silk, D. B. A.

    Published in Proceedings of the Nutrition Society (01-08-2004)
    “…At the outset of the research programme into irritable bowel syndrome (IBS) it was perceived that there was a need to develop a symptom-based classification…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Pseudo-pseudo-obstruction: lessons in diagnosis and management by Silk, D BA

    “…Chronic intestinal pseudo-obstruction (CIP) is a rare and severe motility disorder for which strict diagnostic criteria have been described.It is suggested…”
    Get full text
    Journal Article
  10. 10

    Colonic responses to enteral tube feeding by BOWLING, T E, SILK, D B A

    Published in Gut (01-02-1998)
    “…In the low load groups, where motility remains unchanged from the fasting state and secretion only occurs in those fed intragastrically, diarrhoea has not been…”
    Get full text
    Journal Article
  11. 11

    In-patient assessment of difficult diarrhoea by Silk, D B

    “…'Diarrhoea' remains a common problem presented to gastroenterologists. Assessment of the history will in most cases point to the investigations that will…”
    Get more information
    Journal Article
  12. 12

    Deranged smooth muscle α-actin as a biomarker of intestinal pseudo-obstruction: a controlled multinational case series by Knowles, C H, Silk, D B A, Darzi, A, Veress, B, Feakins, R, Raimundo, A H, Crompton, T, Browning, E C, Lindberg, G, Martin, J E

    Published in Gut (01-11-2004)
    “…Background and aims: Chronic idiopathic intestinal pseudo-obstruction (CIIP) is a severe motility disorder associated with significant morbidity. Several…”
    Get full text
    Journal Article
  13. 13

    'Idiopathic' intestinal failure - the importance of identifying and treating primary psychopathology by Bourke, J., Soldan, J., Silk, D. B. A., Aziz, Q., Libby, G. W.

    Published in Neurogastroenterology and motility (01-03-2012)
    “…Background  Gastrointestinal neuromuscular disorders (GINMD) are an important cause of intestinal failure (IF). We present six cases of IF in whom a diagnosis…”
    Get full text
    Journal Article
  14. 14

    The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man by Spiller, R C, Trotman, I F, Higgins, B E, Ghatei, M A, Grimble, G K, Lee, Y C, Bloom, S R, Misiewicz, J J, Silk, D B

    Published in Gut (01-04-1984)
    “…The possibility that malabsorbed fat passing through the human ileum exerts an inhibitory feedback control on jejunal motility has been investigated in 24…”
    Get full text
    Journal Article
  15. 15

    Clinically significant benign pneumoperitoneum as a complication of percutaneous endoscopic gastrostomy by Bradley, L J, Greenwood, R J, Silk, D BA

    Published in Clinical rehabilitation (01-03-2003)
    “…Benign pneumoperitoneum is a complication of percutaneous endoscopic gastrostomy (PEG) feeding tube placement. The rate of occurrence is reported as up to 25%…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Relation Between Osmolality Of Diet And Gastrointestinal Side Effects In Enteral Nutrition by Keohane, P. P., Attrill, Helen, Love, Mary, Frost, P., Silk, D. B. A.

    “…One hundred and eighteen patients with normal gastro-intestinal function were randomly allocated to one of three feeding regimens in a double blind study to…”
    Get full text
    Journal Article
  18. 18

    Two phase randomised controlled clinical trial of postoperative oral dietary supplements in surgical patients by Keele, A M, Bray, M J, Emery, P W, Duncan, H D, Silk, D B

    Published in Gut (01-03-1997)
    “…BACKGROUND: Previous work has shown that the administration of oral dietary supplements to patients who have undergone gastrointestinal surgery results in…”
    Get full text
    Journal Article
  19. 19

    The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans by Gabe ,‡, Simon M., Bjarnason §, Ingvar, Tolou–Ghamari ‡, Zahra, Tredger ‡, J.Michael, Johnson ∥, Philip G., Barclay ¶, G.Robin, Williams #, Roger, Silk, David B.A.

    Published in Gastroenterology (New York, N.Y. 1943) (01-07-1998)
    “…Background & Aims: The maintenance of the intestinal mucosal barrier may be energy dependent. Tacrolimus is a potent immunosuppressive drug that decreases…”
    Get full text
    Journal Article
  20. 20